Related Experiment Video
Updated: Jan 19, 2026

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
Published on: June 11, 2015
A Quest of Great Importance-Developing a Broad Spectrum Escherichia coli Phage Collection
Joanna Kaczorowska1, Eoghan Casey2, Horst Neve3
1School of Microbiology and APC Microbiome Ireland, University College Cork, Western Road, T12 YT20 Cork, Ireland. j.m.kaczorowska@amc.uva.nl.
Insights
Bacteriophages (phages) show promise for treating diarrheal diseases caused by Shigella and E. coli in children. This study isolated phages effective against various E. coli strains and some Shigella sonnei.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Background:
- Antibiotic resistance is a growing problem for treating diarrheal diseases in children.
- Enterotoxigenic Escherichia coli (E. coli) and Shigella species are common causes of diarrhea in developing countries.
- Bacteriophages (phages) offer an alternative to antibiotics for bacterial infections.
Purpose of the Study:
- To isolate and characterize bacteriophages capable of infecting E. coli and Shigella species.
- To evaluate the host range and genetic diversity of isolated phages.
- To explore phage therapy as an alternative to antibiotics for pediatric diarrheal diseases.
Main Methods:
- Screening of environmental and industrial water samples for phages.
- Isolation and testing of 19 phages against E. coli (ECOR collection, O157:H7) and Shigella sonnei strains.
- Genome sequencing and morphological characterization of 10 selected phages.
Main Results:
- Nineteen phages were isolated, with 10 selected for further analysis based on distinct host ranges.
- The selected phages infected 61 out of 72 E. coli strains in the ECOR collection.
- Genome analysis revealed five known genetic subgroups and one new subgroup among the isolated phages.
Conclusions:
- Isolated bacteriophages demonstrate broad host ranges against E. coli and potential for Shigella infection.
- Phage therapy is a viable alternative to antibiotics for combating pediatric diarrheal diseases.
- Further research into phage genomics and efficacy is warranted.
Abstract:
Shigella ssp. and enterotoxigenic Escherichia coli are the most common etiological agents of diarrheal diseases in malnourished children under five years of age in developing countries. The ever-growing issue of antibiotic resistance and the potential negative impact of antibiotic use on infant commensal microbiota are significant challenges to current therapeutic approaches. Bacteriophages (or phages) represent an alternative treatment that can be used to treat specific bacterial infections. In the present study, we screened water samples from both environmental and industrial sources for phages capable of infecting E. coli laboratory strains within our collection. Nineteen phages were isolatedand tested for their ability to infect strains within the ECOR collection and E. coli O157:H7 Δstx. Furthermore, since coliphages have been reported to cross-infect certain Shigella spp., we also evaluated the ability of the nineteen phages to infect a representative Shigella sonnei strain from our collection. Based on having distinct (although overlapping in some cases) host ranges, ten phage isolates were selected for genome sequence and morphological characterization. Together, these ten selected phages were shown to infect most of the ECOR library, with 61 of the 72 strains infected by at least one phage from our collection. Genome analysis of the ten phages allowed classification into five previously described genetic subgroups plus one previously underrepresented subgroup.
Related Concept Videos
Viral Replication: Lytic Cycle
DNA Bacteriophages

